Hot Features
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID al... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 6 | 4.43622920518 | 135.25 | 141.25 | 133.75 | 119 | 137.2489039 | DE |
| 4 | 18.35 | 14.9308380797 | 122.9 | 141.25 | 119.95 | 172 | 131.38724327 | DE |
| 12 | -30.35 | -17.6864801865 | 171.6 | 174.3 | 119.95 | 193 | 135.29560842 | DE |
| 26 | -102.65 | -42.0869208692 | 243.9 | 257.39999 | 119.95 | 127 | 157.2737326 | DE |
| 52 | -112.25 | -44.2800788955 | 253.5 | 318 | 119.95 | 90 | 188.51828079 | DE |
| 156 | -42.45 | -23.108328797 | 183.7 | 318 | 119.95 | 87 | 190.37971941 | DE |
| 260 | -42.45 | -23.108328797 | 183.7 | 318 | 119.95 | 87 | 190.37971941 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.